ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Flagship Pioneering, Inc.
FL111 is seeking an independent and motivated lab scientist with deep understanding of biochemical and biophysical assay design to join the Biochemistry team. This role will lead assay development, target engagement studies, and binding characterization for small molecules, heterobifunctionals, and related modalities, working closely with chemistry and biology to inform hit-to-lead optimization and mechanism-of-action questions. The role also contributes to team leadership, cross-functional collaborations, and broader scientific discussions that support organizational growth.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Founded
2000
Flagship Pioneering is a venture creation and investment firm that invents, builds, and funds early-stage companies in biotechnology, life sciences, and sustainability. Using an integrated model of in-house science, lab infrastructure, capital, and operational support, it spins out and scales breakthrough ventures — it has helped found more than 100 companies, including high-profile names such as Moderna. Flagship focuses on deep‑science innovation and long‑term partnerships to translate novel discoveries into transformative products for human health and the planet.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Flagship Pioneering, Inc..
45% above the average for this role
individual investors who own 52% along with institutions invested in Seres Therapeutics, Inc. (NASDAQ:MCRB) saw increase in their holdings value last week
Jul 20, 2025
Associate Scientist I, Biochemistry
Pliant Therapeutics, Inc.
Research Associate
Transitionbio
Principal Scientist – Lead Discovery and Targeted Protein Degradation Biochemistry
Amgen
Distinguished Scientist, Small Molecule Therapeutics
Lila Sciences
Director, Discovery Biology
Neurocrine Biosciences
Postdoctoral Researcher - Contraceptive Drug Discovery
University Health Network
